Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.
This paper considers the analysis of longitudinal data complicated by the fact that during follow-up patients can be in different disease states, such as remission, relapse or death. If both the response of interest (for example, quality of life (QOL)) and the amount of missing data depend on this disease state, ignoring the disease state will yield biased means. Death as the final state is an additional complication because no measurements after death are taken and often the outcome of interest is undefined after death. We discuss a new approach to model these types of data. In our approach the probability to be in each of the different disease states over time is estimated using multi-state models. In each different disease state, the conditional mean given the disease state is modeled directly. Generalized estimation equations are used to estimate the parameters of the conditional means, with inverse probability weights to account for unobserved responses. This approach shows the effect of the disease state on the longitudinal response. Furthermore, it yields estimates of the overall mean response over time, either conditionally on being alive or after inputting predefined values for the response after death. Graphical methods to visualize the joint distribution of disease state and response are discussed. As an example, the analysis of a Dutch randomized clinical trial for breast cancer is considered. In this study, the long-term impact on the QOL for two different chemotherapy schedules was studied with three disease states: alive without relapse, alive after relapse and death.
le Cessie
Saskia
S
Department of Medical Statistics and Bioinformatics, S5-P, Leiden University Medical Centre, P.O. Box 9604, 2300 RC Leiden, The Netherlands. cessie@lumc.nl
de Vries
Elisabeth G E
EG
Buijs
Ciska
C
Post
Wendy J
WJ
D000465:Algorithms; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D003198:Computer Simulation; D003643:Death; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D015233:Models, Statistical; D015337:Multicenter Studies as Topic; D009426:Netherlands; D011336:Probability; D016016:Proportional Hazards Models; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012044:Regression Analysis; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents